Advertisement

Topics

Alnylam Announces Alignment on Value-Based Agreements with Leading Health Insurers and Launches Comprehensive Patient Support Services for ONPATTRO™ (patisiran)

14:37 EDT 10 Aug 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
− Structure of Value-Based Arrangements Agreed in Principle with Harvard Pilgrim Health Care and Other Major Health Insurers – − Alnylam Assist™ Program Designed to Facilitate Access to ONPATTRO and Provide Dedi...

Other Sources for this Article

Alnylam Pharmaceuticals, Inc.
Christine Regan Lindenboom, 617-682-4340
(Investors and Media)
or
Josh Brodsky, 617-551-8276
(Investors)

NEXT ARTICLE

More From BioPortfolio on "Alnylam Announces Alignment on Value-Based Agreements with Leading Health Insurers and Launches Comprehensive Patient Support Services for ONPATTRO™ (patisiran)"

Advertisement
Quick Search
Advertisement
Advertisement